The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors (EMPRESS)
Clinical trial NCT02323854 · COMPLETED
Trial details
- NCT number
- NCT02323854
- Sponsor
- Medtronic - MITG
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2017-03-13
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.